Clinical evaluation of treatment with ciprofloxacin.
D000005:Abdomen; D000038:Abscess / Q000188:drug therapy / Q000382:microbiology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D001991:Bronchitis / Q000188:drug therapy / Q000382:microbiology; D002481:Cellulitis / Q000188:drug therapy* / Q000382:microbiology; D002939:Ciprofloxacin; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy / Q000382:microbiology; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D000890:Anti-Infective Agents; D011804:Quinolines; D002939:Ciprofloxacin